| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0006-291X(69)90278-2 |
| P698 | PubMed publication ID | 4239105 |
| P2093 | author name string | R W Colman | |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | plasminogen | Q107129060 |
| P304 | page(s) | 273-279 | |
| P577 | publication date | 1969-04-01 | |
| P1433 | published in | Biochemical and Biophysical Research Communications | Q864228 |
| P1476 | title | Activation of plasminogen by human plasma kallikrein | |
| P478 | volume | 35 |
| Q70260301 | A comparision of the abilities of plasma kallikrein, β-factor XIIa, factor XIa and urokinase to activate plasminogen |
| Q28357136 | A plasma kallikrein-dependent plasminogen cascade required for adipocyte differentiation |
| Q35321833 | Activation of plasminogen to plasmin by a protease associated with the outer membrane of Escherichia coli |
| Q28365898 | Anaphylactic release of a prekallikrein activator from human lung in vitro |
| Q47911391 | Antithrombin agents as anticoagulants and antithrombotics. Implications in drug development |
| Q36337574 | Bacterial plasminogen receptors utilize host plasminogen system for effective invasion and dissemination |
| Q57292290 | Blood-derived plasminogen drives brain inflammation and plaque deposition in a mouse model of Alzheimer's disease |
| Q31132259 | C1 esterase inhibitor reduces lower extremity ischemia/reperfusion injury and associated lung damage |
| Q40684870 | C1-inhibitor substitution therapy in septic shock and in the vascular leak syndrome induced by high doses of interleukin-2. |
| Q64093592 | Coagulation Pathways in Neurological Diseases: Multiple Sclerosis |
| Q34534792 | Demonstration of modified inactive first component of complement (C1) inhibitor in the plasmas of C1 inhibitor-deficient patients |
| Q39915056 | Disseminated intravascular coagulation (DIC): An approach |
| Q36343908 | Dissemination of contact activation in plasma by plasma kallikrein |
| Q38020323 | FXII. |
| Q36037758 | Formation of bradykinin: a major contributor to the innate inflammatory response |
| Q47284399 | Fourier transform infrared (FT-IR) spectroscopic studies of peptide models for interaction of the binding regions of high molecular weight kininogen and prekallikrein |
| Q41295455 | Hageman factor substrates. Human plasma prekallikrein: mechanism of activation by Hageman factor and participation in hageman factor-dependent fibrinolysis |
| Q34741422 | Hereditary angioedema: a current state-of-the-art review, III: mechanisms of hereditary angioedema |
| Q36270035 | Human plasma alpha 2-macroglobulin. An inhibitor of plasma kallikrein |
| Q40983434 | Inactivation of kallikrein in human plasma |
| Q40427326 | Inactivation of various proteinase inhibitors and the complement system in human plasma by the 56-kilodalton proteinase from Serratia marcescens |
| Q36343228 | Induction of acute cholecystitis by activation of factor XII. |
| Q33982766 | Initiation of plasma prorenin activation by Hageman factor-dependent conversion of plasma prekallikrein to kallikrein |
| Q36988995 | Isolation from human plasma of a plasminogen activator identical to urinary high molecular weight urokinase |
| Q39626923 | Isolation of plasminogen activator from human plasma by chromatography on lysine-Sepharose |
| Q34277029 | Kallikrein-like activity of crotalase, a snake venom enzyme that clots fibrinogen |
| Q35207230 | Mechanisms of activation of the classical pathway of complement by Hageman factor fragment |
| Q40115113 | Molecular mechanism of complex infection by bacteria and virus analyzed by a model using serratial protease and influenza virus in mice |
| Q33768031 | New insights into the role of Plg-RKT in macrophage recruitment |
| Q38994649 | Plasma kallikrein mediates brain hemorrhage and edema caused by tissue plasminogen activator therapy in mice after stroke |
| Q34766934 | Plasminogen activation independent of uPA and tPA maintains wound healing in gene-deficient mice. |
| Q69622791 | Primary Fibrinolytic Syndrome Associated With Subarachnoid Hemorrhage: a Case Report |
| Q35818183 | Recombinant alpha 1-antitrypsin Pittsburgh attenuates experimental gram-negative septicemia |
| Q40115888 | Relationships among the complement, kinin, coagulation, and fibrinolytic systems |
| Q38269009 | Role of the kallikrein-kinin system in traumatic brain injury |
| Q40266462 | Selected hemostatic abnormalities associated with neoplastic disease. |
| Q39787634 | Separation of Kininogens by Gel Filtration of Plasminogen-free Human Plasma |
| Q40393763 | Significance of the Regulation of Plasma Kallikrein by α2Ma |
| Q40176847 | Subunits of human plasma kininase II generated by plasma kallikrein |
| Q34608959 | Surface-mediated defense reactions. The plasma contact activation system |
| Q40104724 | The Biochemistry and Pathophysiology of the Contact System of Plasma |
| Q41171782 | The Effects of the Contact Activation System on Hemorrhage |
| Q39895979 | The Kinin System and Its Relations to Other Systems |
| Q37029588 | The activation of plasminogen by Hageman factor (Factor XII) and Hageman factor fragments |
| Q39780188 | The contact activation system: biochemistry and interactions of these surface-mediated defense reactions |
| Q36272174 | The fibrinolytic pathway of human plasma. Isolation and characterization of the plasminogen proactivator |
| Q40076028 | The fibrinolytic system in man |
| Q35793741 | The human plasma fibrinolytic system: Regulation and control |
| Q35856747 | The kinin system: its relation to blood coagulation, fibrinolysis and the formed elements of the blood |
| Q46972046 | The major plasma kallikrein inhibitor of guinea pig plasma |
| Q24671642 | The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategies |
| Q41415762 | The purification of a human plasma kallikrein with weak plasminogen activator activity |
| Q36818033 | The purification of human urinary kallikrein with ion-exchange radial flow membrane chromatography |
| Q43426553 | Thrombosis and intravascular coagulation |
Search more.